je.st
news
Tag: msd
MSD Animal Health Receives Marketing Authorization from European Commission for BRAVECTO (fluralaner)
2014-02-17 09:00:00| Merck.com - Corporate News
Dateline City: SUMMIT, N.J. First Chewable Tablet Approved for Fleas and Ticks in Dogs Effective for 12 Weeks (8 Weeks for Rhipicephalus sanguineus Ticks) SUMMIT, N.J.--(BUSINESS WIRE)--MSD Animal Health, known as Merck Animal Health in the United States and Canada, announced today that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has granted marketing authorization for the veterinary medicinal product BRAVECTO (fluralaner) chewable tablets for dogs (112.5 mg, 250 mg, 500 mg, 1000 mg, 1400 mg). Language: English Contact: Media:MSD Animal HealthAmy Firsching, +1 908-473-6357orPam Eisele, +1 908-423-5042 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: health
marketing
european
animal
MSD Animal Health, Utrecht University Partner up to Discover PED Vaccine
2014-02-07 01:00:00| ThePigSite - Industry News
US & NETHERLANDS - MSD Animal Health (known as Merck Animal Health in the USA and Canada) announced that it has entered into a research agreement with Utrecht University to test leads towards a vaccine for Porcine Epidemic Diarrhea Virus. Research has already begun under the agreement, which will last 12 months.
Tags: health
university
partner
animal
MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO (fluralaner)
2013-12-17 10:00:00| Merck.com - Corporate News
Dateline City: SUMMIT, N.J. New Chewable Tablet Treatment for Fleas and Ticks in Dogs Effective For 12 Weeks (8 weeks for Rhipicephalus sanguineus ticks) SUMMIT, N.J.--(BUSINESS WIRE)--MSD Animal Health (known as Merck Animal Health in the United States and Canada) today announced that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency has adopted a positive opinion, recommending the granting of a marketing authorization for the veterinary medicinal product BRAVECTO (fluralaner) chewable tablets for dogs (112.5 mg, 250 mg, 500 mg, 1000 mg, 1400 mg). Language: English Contact: MSD Animal HealthAmy Firsching, +1 908 473 6357amy.firsching@merck.comorPam Eisele, +1 908 423 5042pamela_eisele@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: health
positive
opinion
agency
MSD Animal Health Presents Important Data at Asian Pig Veterinary Society Congress
2013-09-24 02:00:00| ThePigSite - Industry News
VIET NAM - MSD Animal Health (known as Merck Animal Health in the USA and Canada) announced that data related to its swine products and product-related services will be presented at the 6th Asian Pig Veterinary Society (APVS) Congress on 23 to 25 September 2013 in Ho Chi Minh City.
Tags: data
health
important
society
MSD Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin
2013-07-26 16:16:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck Sharpe and Dohme (MSD), known as Merck in the United States and Canada, issued the following statement regarding the conclusion of the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) review of GLP-1, or incretin-based, therapies, including sitagliptin. Language: English Contact: MSDMedia:Pam Eisele, +1-908-423-5042Michael Close, +1-267-305-1211Investor:Carol Ferguson, +1-908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: type
including
review
statement